Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| SPRY (ARS Pharmaceuticals, Inc.) | -19.23% | -35.24% | 12.49% | -21.78% | NA | NA | NA | … | … |
Data as of 06/09/2026, Common starting date is 12/04/2020
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| SPRY (ARS Pharmaceuticals, Inc.) | 12/04/2020 | 06/09/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | 5.73 | -35.24 | 12.49 | -21.78 | NA | NA | NA | … | … | -19.23 | 7.87 | 96.90 | -35.76 | 28.08 | -85.63 | 85.36 |
| Sharpe Ratio | NA | -0.58 | 0.05 | -0.30 | NA | NA | NA | … | … | -0.82 | 0.08 | 1.45 | -0.34 | 0.41 | -1.01 | 6,657.51 |
| Standard Deviation(%) | NA | 66.64 | 79.35 | 81.26 | NA | NA | NA | … | … | 65.55 | 67.90 | 63.04 | 119.42 | 64.89 | 85.13 | 84.89 |
| Draw Down(%) | NA | 63.32 | 63.32 | 91.77 | NA | NA | NA | … | … | 45.10 | 63.32 | 38.31 | 67.95 | 56.97 | 90.02 | 5.02 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/09/2026, Common starting date is 12/04/2020
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| SPRY (ARS Pharmaceuticals, Inc.) |
-47.90%
Jan 2021 – Jan 2024 |
-28.72%
Mar 2021 – Mar 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| SPRY (ARS Pharmaceuticals, Inc.) |
65.00%
Apr 2022 – Apr 2025 |
-19.91%
May 2021 – May 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart